Adam Maeder

Stock Analyst at Piper Sandler

(0.61)
# 1989
Out of 5,266 analysts
130
Total ratings
56.72%
Success rate
6.77%
Average return
20 Stocks
Name Action Price Target Current % Upside Ratings Updated
Edwards Lifesciences
Maintains: Neutral
70 73
73.45 -0.61% 13 Feb 12, 2025
Inspire Medical Syst...
Maintains: Overweight
260 233
174.62 33.43% 14 Feb 10, 2025
Nevro
Upgrades: Neutral
6 6
5.74 1.92% 16 Feb 7, 2025
ResMed
Maintains: Neutral
252 260
230.92 12.59% 2 Jan 31, 2025
Intuitive Surgical
Reiterates: Overweight
538 670
592.24 13.13% 18 Jan 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
52 80
79.97 0.04% 7 Jan 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
12 11
14.22 -26.16% 6 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
131 133
135.25 -1.66% 2 Oct 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
5 5
3.23 39.32% 3 Sep 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
20 21
15.06 39.44% 2 May 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
18 20
n/a n/a 6 May 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
290 360
n/a n/a 10 Apr 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
7 8
4.18 91.39% 1 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
15 20
10.37 92.86% 8 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
75 71
n/a n/a 8 Jan 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
25 30
15.05 99.34% 2 May 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
6 5
2.23 124.22% 2 Mar 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
10 18
7.29 146.91% 2 Jan 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
104 99
47.7 107.55% 3 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
9 11
n/a n/a 5 Jun 14, 2021